US Pharma MarketingCVS to expand biosimilar formulary adoptions to improve affordability, accessibility
The move to prioritize biosimilars comes as the company seeks to improve affordability, access and value. Changes will be effective July 1.
The move to prioritize biosimilars comes as the company seeks to improve affordability, access and value. Changes will be effective July 1.
Source: Fierce Healthcare